Use access key #2 to skip to page content.
$21.14 0.51 (2.47%)
12/3/2008 4:00 PM

Illumina, Inc. (ILMN)

CAPS Rating:
***

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

View Ticker Page (ILMN)

Results 21 - 30 of 59 :   12345Next »

Recs

0

Avatar Tuusa (53.29) Submitted: 11/13/08 2:04 PM : Outperform Start Price: $24.65 ILMN Score: -16.50

Gene research is the wave of the future. It will be a foundation for all medical research into disease, cancer, diabetes, etc. It even has growing foundations in athletics. Solid company in a small market in a new break through area. However, there i...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar tstokesbme (40.48) Submitted: 11/09/08 4:13 PM : Outperform Start Price: $29.49 ILMN Score: -19.83

I work in the field of microarray analysis. Illumina data formats are much harder to process than Affymetrix formats, but from what I've seen in adoption and better signal fidelity, I think they will start to take away significant market share. Still...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar jawortham (66.64) Submitted: 10/29/08 8:14 PM : Outperform Start Price: $28.48 ILMN Score: -16.44

Biotech is in an infancy like electronics in the 60's, before lithography based transistors. The seeds of the 60's didn't began their most aggressive sprout in the 80's & 90's, but still made some money before the 80's.


The genome is the ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Rep07 (96.53) Submitted: 10/28/08 1:43 PM : Outperform Start Price: $25.42 ILMN Score: -17.61

Taking a chance on a growth/innovation pick here though it's not really my style. Supposedly products favored over cometitors'. Does this justify price? I dunno. But fools love stories like this, so maybe there will be lemming momentum. No BV or...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar alvojiggy1 (94.88) Submitted: 10/22/08 8:50 PM : Underperform Start Price: $25.95 ILMN Score: 14.79

high debt to equity. forward P/E is low

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar inhabitdesigns (< 20) Submitted: 10/22/08 7:14 PM : Outperform Start Price: $25.95 ILMN Score: -14.79

leading genetic analysis





revenues grew past 3 quarters


Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar yeraz (< 20) Submitted: 10/11/08 9:08 PM : Outperform Start Price: $28.68 ILMN Score: -18.48

A leader in the technology that determines the genotype of individuals. The information can be used for personalized medicine.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar bclan13 (99.52) Submitted: 10/11/08 7:32 PM : Outperform Start Price: $28.68 ILMN Score: -18.48

very attractive growth rate, and able to raise capital recently. Should be able to support operations and R&D with retained earnings from this point forward.

Illumina could be an acquisition target for large industrial firms looking at lif...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ecabiac (20.77) Submitted: 10/07/08 9:44 PM : Underperform Start Price: $30.01 ILMN Score: 19.01

Strong profit margins but not a sustainable P/E. Definitely overbought on hopes of a big jump, but will likely remain stagnant in the short term as cutbacks in research follow current economic conditions. Might be a better buy when the clouds start t...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar portfolio2008 (< 20) Submitted: 9/18/08 11:31 AM : Outperform Start Price: $37.32 ILMN Score: -18.02

TM likes long-term, sitting at 200 dma.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links